H19 can promote the proliferation and self-renewal of glioma stem cells, and promote the migration and metastasis of tumor cells through different mechanisms, including the regulatory relationship with miRNA, EZH2-mediated epigenetic regulation, etc. Therefore, H19 may serve as a therapeutic target for glioma stem cells and tumor migration. The gene discussed is EZH2; the disease is central nervous system cancer.